All > Vision > Minneapolis

small scotoma using Head Mounted Display No re-mapping for Age-related Macular Degeneration

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Age-related Macular DegenerationLarge scotoma using Head Mounted Display PLUS re-mapping - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial assesses a device that uses eye trackers and real-time image processing to help people with central vision loss.

Eligible Conditions
  • Age-related Macular Degeneration

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Part B High dose
1
AM712(ASKG712)
1
QA102 200mg group

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 5 years

5 years
Reading speed

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Part B High dose
1
AM712(ASKG712)
2
QA102 200mg group

Trial Design

2 Treatment Groups

small scotoma using Head Mounted Display No re-mapping
1 of 2
Large scotoma using Head Mounted Display PLUS re-mapping
1 of 2

Active Control

70 Total Participants · 2 Treatment Groups

Primary Treatment: small scotoma using Head Mounted Display No re-mapping · No Placebo Group · N/A

small scotoma using Head Mounted Display No re-mappingActiveComparator Group · 2 Interventions: Large scotoma using Head Mounted Display PLUS re-mapping, small scotoma using Head Mounted Display No re-mapping · Intervention Types: Other, Other
Large scotoma using Head Mounted Display PLUS re-mappingActiveComparator Group · 2 Interventions: Large scotoma using Head Mounted Display PLUS re-mapping, small scotoma using Head Mounted Display No re-mapping · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,256 Previous Clinical Trials
1,483,852 Total Patients Enrolled
1 Trials studying Age-related Macular Degeneration
108 Patients Enrolled for Age-related Macular Degeneration
Erik van Kuijk, MD, PhDPrincipal InvestigatorUniversity of Minnesota

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have no cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
You must be at least 18 years old.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top